Soleno Therapeutics (SLNO) Cash from Investing Activities (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.30% |
| Dec 31, 2025 | -37.09% |
| Sep 30, 2025 | -1,055.31% |
| Jun 30, 2025 | -134.51% |
| Mar 31, 2025 | 256.00% |
| Dec 31, 2024 | 59.48% |
| Sep 30, 2024 | 103.34% |
| Jun 30, 2024 | -4.93% |
| Dec 31, 2021 | -160.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2019 | -76.64% |
| Sep 30, 2019 | 7,450.00% |
| Jun 30, 2019 | 40.00% |
| Mar 31, 2019 | 94.25% |
| Dec 31, 2018 | -3,380.00% |
| Dec 31, 2017 | -89.51% |
| Mar 31, 2017 | 76.02% |
| Dec 31, 2016 | -198.12% |
| Sep 30, 2016 | 185.00% |
| Jun 30, 2016 | -5.26% |
| Mar 31, 2016 | 40.21% |
| Dec 31, 2015 | 97.47% |
| Sep 30, 2015 | -4,093.33% |
| Jun 30, 2015 | -2,900.00% |
| Jun 30, 2014 | -175.00% |
| Mar 31, 2014 | 1,559.85% |